iving antiplatelet
therapies by providing industry-leading and widely accessible diagnostic
tests for rapid platelet function assessment.
VerifyNow is the first simple and rapid system for measuring the
individual response to multiple antiplatelet agents. Addressing every major
antiplatelet drug, including FDA-cleared products for aspirin, Plavix(R),
ReoPro(R), and Integrilin(R), the VerifyNow system provides a valuable tool
to help physicians make informed treatment decisions.
The Accumetrics logo and VerifyNow are registered trademarks of
Accumetrics, Inc., ReoPro is a registered trademark of Centocor, Inc.
Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix
is a registered trademark of Sanofi-Aventis.
CONTACT: Jules Abraham
Lippert Heilshorn & Associates
212-838-3777
jabraham@lhai.com
'/>"/>SOURCE Accumetrics, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
HeartWare Appoints Timothy J. Barberich to Board of Directors2.
Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.3.
Wyeth Announces Election of Timothy P. Cost as Senior Vice President, Corporate Affairs4.
SRA Names Timothy J. Atkin Senior Vice President of Global Health Business; Appoints Mike Toner Global Health Unit Chief Financial Officer5.
CuraGen Corporation Announces Appointment of Dr. Timothy M. Shannon as President and Chief Executive Officer6.
Excalibur - Transforming Biotech Deals can Still be Achieved7.
Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director8.
Still River Systems Announces Operation of the Worlds Highest Magnetic Field Cyclotron9.
Federal nanotech risk research plan still comes up short10.
Lethal Human H5N1 Influenza Virus Replikin Gene Still Upregulated11.
Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health